Filing Details
- Accession Number:
- 0001127602-25-001618
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-21 16:02:18
- Reporting Period:
- 2025-01-17
- Accepted Time:
- 2025-01-21 16:02:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657720 | Pascal Deschatelets | C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue, 3Rd Floor Waltham MA 02451 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-17 | 750 | $29.96 | 1,137,445 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-01-21 | 15,045 | $0.00 | 1,152,490 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Footnotes
- This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
- This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.
Billionaire Hedge Funds
